This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Thermi’s Temperature-Controlled Radiofrequency Technology Approved In Canada To Treat Dermal Laxity
Thermi®, an Almirall S.A. company and pioneer in temperature-controlled radiofrequency (RF) technology, announced it has been issued a medical device license from Health Canada to market the company’s Thermi RF system for